| 12012468 |
Cyclic polypeptides for PCSK9 inhibition |
Alonso Ricardo, Thomas J. Tucker, Nicolas Cedric Boyer, Joseph R. Stringer, Derek M. LaPlaca +15 more |
2024-06-18 |
$764,067,000 |
| 11530244 |
Cyclic polypeptides for PCSK9 inhibition |
Alonso Ricardo, Thomas J. Tucker, Nicolas Cedric Boyer, Joseph R. Stringer, Derek M. LaPlaca +15 more |
2022-12-20 |
$609,105,000 |
| 11161819 |
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists |
Gregory L. Adams, Jason M. Cox, John S. Debenham, Scott D. Edmondson, Yan Guo +15 more |
2021-11-02 |
$152,718,000 |
| 9687494 |
Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use |
Jack D. Scott, Andrew Stamford, Jared N. Cumming, Ulrich Iserloh |
2017-06-27 |
$105,730,000 |
| 9499502 |
5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use |
Wen-Lian Wu, Duane A. Burnett, Andrew Stamford, Jared N. Cumming, Chad E. Bennett +3 more |
2016-11-22 |
$87,862,000 |
| 9475785 |
Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use |
Jack D. Scott, Andrew Stamford, Jared N. Cumming, Ulrich Iserloh, Jeffrey A. Misiaszek +1 more |
2016-10-25 |
$117,189,000 |
| 9453034 |
C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use |
Jared N. Cumming, Jack D. Scott, Wen-Lian Wu, Duane A. Burnett, Andrew Stamford |
2016-09-27 |
$133,879,000 |
| 9428475 |
Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use |
Jack D. Scott, Andrew Stamford, Jared N. Cumming |
2016-08-30 |
$102,397,000 |
| 9422277 |
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use |
Jared N. Cumming, Andrew Stamford, Younong Yu, Jack D. Scott, Ulrich Iserloh |
2016-08-23 |
$79,861,000 |
| 9416129 |
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use |
Jared N. Cumming, Andrew Stamford, Younong Yu, Jack D. Scott, Ulrich Iserloh +2 more |
2016-08-16 |
$77,022,000 |
| 9221839 |
C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use |
Jared N. Cumming, Andrew Stamford |
2015-12-29 |
$79,567,000 |
| 9145426 |
Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use |
Andrew Stamford, Jared N. Cumming |
2015-09-29 |
$91,284,000 |
| 9029362 |
Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use |
Jack D. Scott, Andrew Stamford, Jared N. Cumming |
2015-05-12 |
$67,061,000 |
| 8940748 |
Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use |
Jack D. Scott, Andrew Stamford, Jared N. Cumming, Ulrich Iserloh |
2015-01-27 |
$77,486,000 |
| 8735604 |
Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use |
Michael Miller, Duane DeMong, Andrew Stamford, William J. Greenlee |
2014-05-27 |
$108,716,000 |
| 8729071 |
Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use |
Jack D. Scott, Andrew Stamford, Jared N. Cumming |
2014-05-20 |
$165,314,000 |
| 8623873 |
Substituted piperazines as CB1 antagonists |
Michael Miller, Jack D. Scott, Duane DeMong, Andrew Stamford, William J. Greenlee +1 more |
2014-01-07 |
|
| 8563543 |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
Jack D. Scott, Andrew Stamford, Jared N. Cumming, Ulrich Iserloh, Lingyan Wang +1 more |
2013-10-22 |
$71,032,000 |
| 8470773 |
Thiophenes as glucagon receptor antagonists, compositions, and methods for their use |
Michael Miller, Andrew Stamford, William J. Greenlee |
2013-06-25 |
$46,267,000 |
| 8236805 |
Substituted piperazines as CB1 antagonists |
Michael Miller, Jack D. Scott, Andrew Stamford, William J. Greenlee, Jay Weinstein |
2012-08-07 |
|
| 8114879 |
Piperazine derivatives useful as CCR5 antagonists |
Bahige M. Baroudy, John W. Clader, Hubert Josien, Stuart W. McCombie, Brian McKittrick +9 more |
2012-02-14 |
|
| 7750158 |
Cannabinoid receptor ligands |
Bandarpalle B. Shankar, Razia Rizvi, Chunli Huang, Joseph A. Kozlowski, Stuart W. McCombie +1 more |
2010-07-06 |
|
| 7705153 |
Bipiperdine derivatives useful as CCR3 antagonists |
Pauline C. Ting, Jianhua Cao, Youhao Dong, Ying Huang, Joseph M. Kelly +2 more |
2010-04-27 |
|
| 7700597 |
Substituted piperazines as CB1 antagonists |
Michael Miller, Jack D. Scott, Andrew Stamford, William J. Greenlee, Jay Weinstein |
2010-04-20 |
|
| 7384944 |
Piperazine derivatives useful as CCR5 antagonists |
Bahige M. Baroudy, John W. Clader, Hubert Josien, Stuart W. McCombie, Brian McKittrick +9 more |
2008-06-10 |
$175,193,000 |
